524 related articles for article (PubMed ID: 20373901)
1. Augmentation of macular pigment following supplementation with all three macular carotenoids: an exploratory study.
Connolly EE; Beatty S; Thurnham DI; Loughman J; Howard AN; Stack J; Nolan JM
Curr Eye Res; 2010 Apr; 35(4):335-51. PubMed ID: 20373901
[TBL] [Abstract][Full Text] [Related]
2. Serum and retinal responses to three different doses of macular carotenoids over 12 weeks of supplementation.
Stringham JM; Stringham NT
Exp Eye Res; 2016 Oct; 151():1-8. PubMed ID: 27426932
[TBL] [Abstract][Full Text] [Related]
3. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study.
Trieschmann M; Beatty S; Nolan JM; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Exp Eye Res; 2007 Apr; 84(4):718-28. PubMed ID: 17306793
[TBL] [Abstract][Full Text] [Related]
4. Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
Thurnham DI; Nolan JM; Howard AN; Beatty S
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1231-43. PubMed ID: 25311651
[TBL] [Abstract][Full Text] [Related]
5. Macular carotenoid supplementation in subjects with atypical spatial profiles of macular pigment.
Nolan JM; Akkali MC; Loughman J; Howard AN; Beatty S
Exp Eye Res; 2012 Aug; 101():9-15. PubMed ID: 22652506
[TBL] [Abstract][Full Text] [Related]
6. The heritability of macular response to supplemental lutein and zeaxanthin: a classic twin study.
Hammond CJ; Liew SH; Van Kuijk FJ; Beatty S; Nolan JM; Spector TD; Gilbert CE
Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4963-8. PubMed ID: 22700713
[TBL] [Abstract][Full Text] [Related]
7. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation.
Wenzel AJ; Sheehan JP; Gerweck C; Stringham JM; Fuld K; Curran-Celentano J
Ophthalmic Physiol Opt; 2007 Jul; 27(4):329-35. PubMed ID: 17584283
[TBL] [Abstract][Full Text] [Related]
8. Supplementation with all three macular carotenoids: response, stability, and safety.
Connolly EE; Beatty S; Loughman J; Howard AN; Louw MS; Nolan JM
Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):9207-17. PubMed ID: 21979997
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
[TBL] [Abstract][Full Text] [Related]
10. The association between macular pigment optical density and CFH, ARMS2, C2/BF, and C3 genotype.
Loane E; Nolan JM; McKay GJ; Beatty S
Exp Eye Res; 2011 Nov; 93(5):592-8. PubMed ID: 21816153
[TBL] [Abstract][Full Text] [Related]
11. A central dip in the macular pigment spatial profile is associated with age and smoking.
Kirby ML; Beatty S; Loane E; Akkali MC; Connolly EE; Stack J; Nolan JM
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6722-8. PubMed ID: 20592234
[TBL] [Abstract][Full Text] [Related]
12. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
Nolan JM; Stack J; O'connell E; Beatty S
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
[TBL] [Abstract][Full Text] [Related]
13. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
14. Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations.
Aleman TS; Cideciyan AV; Windsor EA; Schwartz SB; Swider M; Chico JD; Sumaroka A; Pantelyat AY; Duncan KG; Gardner LM; Emmons JM; Steinberg JD; Stone EM; Jacobson SG
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1319-29. PubMed ID: 17325179
[TBL] [Abstract][Full Text] [Related]
15. Spatial profile of macular pigment and its relationship to foveal architecture.
Nolan JM; Stringham JM; Beatty S; Snodderly DM
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2134-42. PubMed ID: 18436846
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, placebo-controlled study of zeaxanthin and visual function in patients with atrophic age-related macular degeneration: the Zeaxanthin and Visual Function Study (ZVF) FDA IND #78, 973.
Richer SP; Stiles W; Graham-Hoffman K; Levin M; Ruskin D; Wrobel J; Park DW; Thomas C
Optometry; 2011 Nov; 82(11):667-680.e6. PubMed ID: 22027699
[TBL] [Abstract][Full Text] [Related]
17. Central Retinal Enrichment Supplementation Trials (CREST): design and methodology of the CREST randomized controlled trials.
Akuffo KO; Beatty S; Stack J; Dennison J; O'Regan S; Meagher KA; Peto T; Nolan J
Ophthalmic Epidemiol; 2014 Apr; 21(2):111-23. PubMed ID: 24621122
[TBL] [Abstract][Full Text] [Related]
18. Macular pigment density variation after supplementation of lutein and zeaxanthin using the Visucam
Azar G; Quaranta-El Maftouhi M; Masella JJ; Mauget-Faÿsse M
J Fr Ophtalmol; 2017 Apr; 40(4):303-313. PubMed ID: 28336284
[TBL] [Abstract][Full Text] [Related]
19. Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing.
Nolan JM; Kenny R; O'Regan C; Cronin H; Loughman J; Connolly EE; Kearney P; Loane E; Beatty S
Ophthalmic Res; 2010; 44(2):131-9. PubMed ID: 20516725
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E genotype is associated with macular pigment optical density.
Loane E; McKay GJ; Nolan JM; Beatty S
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2636-43. PubMed ID: 20107178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
